Prevalence of Fabry disease in patients with stroke

Prevalence of Fabry disease in patients with stroke - Fabry stroke screening study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016404

Enrollment

100

Registered

2015-02-01

Start date

2015-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fabry disease

Interventions

We take blood sample of 2ml for the patients.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cerebral infarction Cerebral hemorrhage

Exclusion criteria

Exclusion criteria: Cardioembolic Subarachnoid hemorrhage

Design outcomes

Primary

Measure	Time frame
Plasma globotriaosylsphingosine (Lyso-Gb3)	—

Secondary

Measure	Time frame
Plasma enzymatic activity of alpha-galactsidase	—

Countries

Japan

Contacts

Public ContactManabu Iwata

Hirosaki Stroke and Rehabilitation Center Department of Rehabilitation

iwata-m@umin.ac.jp0172-28-8220

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026